Indivior (NASDAQ:INDV) Shares Gap Down to $20.34

Shares of Indivior PLC (NASDAQ:INDV) gapped down prior to trading on Friday . The stock had previously closed at $20.34, but opened at $19.74. Indivior shares last traded at $19.69, with a volume of 13,761 shares traded.

Wall Street Analyst Weigh In

Separately, Craig Hallum assumed coverage on Indivior in a research report on Wednesday, April 3rd. They issued a “buy” rating and a $37.00 target price on the stock.

Indivior Stock Down 5.0 %

The stock’s 50 day moving average is $20.31 and its 200-day moving average is $18.49. The company has a market cap of $2.66 billion, a PE ratio of -965.52 and a beta of 0.46.

Indivior (NASDAQ:INDV) last posted its earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15. The firm had revenue of $293.00 million for the quarter, compared to the consensus estimate of $260.00 million. Indivior had a net margin of 0.18% and a return on equity of 538.18%. On average, analysts anticipate that Indivior PLC will post 2.03 EPS for the current fiscal year.

Institutional Trading of Indivior

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Liontrust Investment Partners LLP bought a new position in Indivior during the third quarter valued at $43,340,000. Vanguard Group Inc. grew its holdings in Indivior by 1.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,846,354 shares of the company’s stock valued at $134,875,000 after purchasing an additional 90,673 shares during the last quarter. Deutsche Bank AG purchased a new stake in Indivior in the 3rd quarter worth about $3,181,000. FMR LLC lifted its stake in Indivior by 53.5% in the third quarter. FMR LLC now owns 5,498,087 shares of the company’s stock worth $119,339,000 after purchasing an additional 1,915,980 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Indivior by 15.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 39,596 shares of the company’s stock valued at $860,000 after buying an additional 5,365 shares during the period. Hedge funds and other institutional investors own 60.33% of the company’s stock.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.